{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:34:39Z","timestamp":1794090879213,"version":"4.8.0"},"reference-count":35,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372935, 81271839, 81671971, 81471957 and U1602223"],"award-info":[{"award-number":["81372935, 81271839, 81671971, 81471957 and U1602223"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2017.00175","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T03:41:54Z","timestamp":1494560514000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Effective Protection Induced by a Monovalent DNA Vaccine against Dengue Virus (DV) Serotype 1 and a Bivalent DNA Vaccine against DV1 and DV2 in Mice"],"prefix":"10.3389","volume":"7","author":[{"given":"Xiaoyan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/infdis\/jir279","article-title":"Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate","volume":"204","author":"Anderson","year":"2011","journal-title":"J. Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.5365\/wpsar.2014.5.4.002","article-title":"Epidemiological update on the dengue situation in the Western Pacific Region, (2012)","volume":"6","author":"Arima","year":"2015","journal-title":"West. Pac. Surveill. Response J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0042-6822(91)90809-P","article-title":"Dengue virus premembrane and membrane proteins elicit a protective immune response","volume":"185","author":"Bray","year":"1991","journal-title":"Virology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clim.2016.08.021","article-title":"Immunization with electroporation enhances the protective effect of a DNA vaccine candidate expressing prME antigen against dengue virus serotype 2 infection","volume":"171","author":"Chen","year":"2016","journal-title":"Clin. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"15259","DOI":"10.1073\/pnas.0507320102","article-title":"Dynamic effects of antibody-dependent enhancement on the fitness of viruses","volume":"102","author":"Cummings","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1016\/j.vaccine.2014.07.008","article-title":"Safety, immunogenicity and efficacy of a recombinant tetravalent dengue vaccine: a meta-analysis of randomized trials","volume":"32","author":"Da Costa","year":"2014","journal-title":"Vaccine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1016\/j.vaccine.2015.05.059","article-title":"Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia","volume":"33","author":"Dorigatti","year":"2015","journal-title":"Vaccine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0003749","DOI":"10.1371\/journal.pntd.0003749","article-title":"The complexity of a dengue vaccine: a review of the human antibody response","volume":"9","author":"Flipse","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.1016\/j.vaccine.2015.09.108","article-title":"Development of the Sanofi Pasteur tetravalent dengue vaccine: one more step forward","volume":"33","author":"Guy","year":"2015","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(14)60572-9","article-title":"Dengue","volume":"385","author":"Guzman","year":"2015","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jcv.2014.08.031","article-title":"Advances in the understanding, management, and prevention of dengue","volume":"64","author":"Hermann","year":"2015","journal-title":"J. Clin. Virol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10096-015-2540-5","article-title":"Epidemiology and characteristics of the dengue outbreak in Guangdong, Southern China, in 2014","volume":"35","author":"Huang","year":"2016","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.11599\/germs.2013.1034","article-title":"DNA vaccines: roles against diseases","volume":"3","author":"Khan","year":"2013","journal-title":"Germs"},{"key":"B16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12879-016-1379-4","article-title":"Clinical and epidemiological features of the 2014 large-scale dengue outbreak in Guangzhou city, China","volume":"16","author":"Lin","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1586\/14760584.7.2.175","article-title":"Current progress of DNA vaccine studies in humans","volume":"7","author":"Lu","year":"2008","journal-title":"Expert Rev. Vaccines"},{"key":"B18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.molimm.2012.11.007","article-title":"Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM\/E and NS1: their immunity and protective efficacy in mice","volume":"54","author":"Lu","year":"2013","journal-title":"Mol. Immunol."},{"key":"B19","volume-title":"Dengue Vaccine Enters Phase 3 Trial in Brazil.","year":"2016"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1038\/mt.2008.178","article-title":"Growth hormone-releasing hormone plasmid treatment by electroporation decreases offspring mortality over three pregnancies","volume":"16","author":"Person","year":"2008","journal-title":"Mol. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.1016\/j.vaccine.2015.09.102","article-title":"Nucleic acid (DNA) immunization as a platform for dengue vaccine development","volume":"33","author":"Porter","year":"2015","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e92643","DOI":"10.1371\/journal.pone.0092643","article-title":"Induction of neutralizing antibody response against four dengue viruses in mice by intramuscular electroporation of tetravalent DNA vaccines","volume":"9","author":"Prompetchara","year":"2014","journal-title":"PLoS ONE"},{"key":"B23","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3855\/jidc.5998","article-title":"Characterization of dengue epidemics in mainland China over the past decade","volume":"9","author":"Ren","year":"2015","journal-title":"J. Infect. Dev. Ctries."},{"key":"B24","doi-asserted-by":"publisher","first-page":"20130562","DOI":"10.1098\/rstb.2013.0562","article-title":"Dengue: recent past and future threats","volume":"370","author":"Rogers","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.coi.2011.03.008","article-title":"Electroporation delivery of DNA vaccines: prospects for success","volume":"23","author":"Sardesai","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1016\/j.vaccine.2016.10.001","article-title":"Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs","volume":"34","author":"Sheng","year":"2016","journal-title":"Vaccine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S1473-3099(16)00146-8","article-title":"The global economic burden of dengue: a systematic analysis","volume":"16","author":"Shepard","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/QCO.0b013e32834a1b0b","article-title":"Critical issues in dengue vaccine development","volume":"24","author":"Thomas","year":"2011","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1128\/JVI.02757-13","article-title":"In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses","volume":"88","author":"Wang","year":"2014","journal-title":"J. Virol."},{"key":"B31","volume-title":"Global Strategy for Dengue Prevention and Control, 2012\u20132020","year":"2012"},{"key":"B32","doi-asserted-by":"publisher","first-page":"664","DOI":"10.4269\/ajtmh.2010.09-0755","article-title":"Dengue fever in mainland China","volume":"83","author":"Wu","year":"2010","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e87630","DOI":"10.1371\/journal.pone.0087630","article-title":"Spatiotemporal characterizations of dengue virus in mainland China: insights into the whole genome from 1978 to 2011","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS ONE"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0156548","DOI":"10.1371\/journal.pone.0156548","article-title":"Epidemiological and virological characterizations of the 2014 dengue outbreak in Guangzhou, China","volume":"11","author":"Zhao","year":"2016","journal-title":"PLoS ONE"},{"key":"B35","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.vaccine.2010.11.014","article-title":"Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection","volume":"29","author":"Zheng","year":"2011","journal-title":"Vaccine"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fcimb.2017.00175\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T03:41:57Z","timestamp":1494560517000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fcimb.2017.00175\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,12]]},"references-count":35,"alternative-id":["10.3389\/fcimb.2017.00175"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2017.00175","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,12]]},"article-number":"175"}}